Login
Navigate Fool.com
Will GALT beat
the market?
Community Rating: 1 Star: Ominous

10.92 0.07 (0.65%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.93
Previous Close $10.85
Daily Range $10.37 - $11.27
52-Week Range $3.23 - $19.11
Market Cap $239.5M
P/E Ratio -8.35
Dividend (Yield) $0.00 (0.0%)
Volume 474,722
Average Daily Volume 623,992
Current FY EPS -$0.75

How do you think GALT
will perform against the market?

Top GALT Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

DorminABC (< 20)
Submitted July 15, 2011

Who is John Galt?

0 Replies Reply Report this Post

News & Commentary

Why Plug Power, Varonis Systems, and Galectin Therapeutics Are Today's 3 Best Stocks

Consumer confidence hits a six-year high, adding fuel to the huge run-ups for Plug Power, Varonis Systems, and Galectin Therapeutics.

Upbeat Consumer Confidence Drives Blue Chips Higher

Healthcare Stocks Up Briskly in Afternoon Surge; Galectin Therapeutics Surges on Announcement Specul

Healthcare Stocks Up Briskly in Afternoon Surge; Galectin Therapeutics Surges on Announcement Speculation

Why Galectin Therapeutics, Inc. Shares Soared

Galectin sets the date for the release of its phase 1 study data on GR-MD-02 for nonalcoholic steatohepatitis. Find out what shareholders should really be waiting for.

Monday Sector Laggards: Biotechnology, Drugs

Sector Update: Healthcare Shares Mixed Pre-Market; Nu Skin Surges 26% on $540 K Fine in China

Today's Biggest Stories in Biotech: Galectin Therapeutics Inc, Merrimack Pharmaceuticals and Nektar

Top stories in biotech and healthcare today.

Why Inteliquent, Pacific Biosciences of California, and Galectin Therapeutics Are Today's 3 Best Sto

The S&P 500 advances modestly on strong earnings results as Inteliquent, Pacific Biosciences of California, and Galectin Therapeutics jumped by at least 15%.

Healthcare Stocks Adding to Earlier Gains; Big Rally by Intercept Pharma Also Raising Peers

Sector Update: Healthcare

See More GALT News...

Sector

Healthcare

Industry

Drugs

Galectin Therapeutics Inc. (GALT) Description

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases. Website: http://www.galectintherapeutics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks